Leukocyte Calpain Deficiency Reduces Angiotensin II–Induced Inflammation and Atherosclerosis But Not Abdominal Aortic Aneurysms in Mice

Objective—Angiotensin II (AngII) infusion profoundly increases activity of calpains, calcium-dependent neutral cysteine proteases, in mice. Pharmacological inhibition of calpains attenuates AngII-induced aortic medial macrophage accumulation, atherosclerosis, and abdominal aortic aneurysm in mice. However, the precise functional contribution of leukocyte-derived calpains in AngII-induced vascular pathologies has not been determined. The purpose of this study was to determine whether calpains expressed in bone marrow (BM)–derived cells contribute to AngII-induced atherosclerosis and aortic aneurysms in hypercholesterolemic mice. Approach and Results—To study whether leukocyte calpains contributed to AngII-induced aortic pathologies, irradiated male low-density lipoprotein receptor−/− mice were repopulated with BM-derived cells that were either wild-type or overexpressed calpastatin, the endogenous inhibitor of calpains. Mice were fed a fat-enriched diet and infused with AngII (1000 ng/kg per minute) for 4 weeks. Overexpression of calpastatin in BM-derived cells significantly attenuated AngII-induced atherosclerotic lesion formation in aortic arches, but had no effect on aneurysm formation. Using either BM-derived cells from calpain-1-deficient mice or mice with leukocyte-specific calpain-2 deficiency generated using cre-loxP recombination technology, further studies demonstrated that independent deficiency of either calpain-1 or -2 in leukocytes modestly attenuated AngII-induced atherosclerosis. Calpastatin overexpression significantly attenuated AngII-induced inflammatory responses in macrophages and spleen. Furthermore, calpain inhibition suppressed migration and adhesion of macrophages to endothelial cells in vitro. Calpain inhibition also significantly decreased hypercholesterolemia-induced atherosclerosis in the absence of AngII. Conclusions—The present study demonstrates a pivotal role for BM-derived calpains in mediating AngII-induced atherosclerosis by influencing macrophage function.

[1]  R. Hayes,et al.  Degradation of βII-Spectrin Protein by Calpain-2 and Caspase-3 Under Neurotoxic and Traumatic Brain Injury Conditions , 2015, Molecular Neurobiology.

[2]  Zhenjie Liu,et al.  Monocyte Chemoattractant Protein-1 (MCP-1) Regulates Macrophage Cytotoxicity in Abdominal Aortic Aneurysm , 2014, PloS one.

[3]  A. Chishti,et al.  Calpain-2 Compensation Promotes Angiotensin II-Induced Ascending and Abdominal Aortic Aneurysms in Calpain-1 Deficient Mice , 2013, PloS one.

[4]  Fukun W. Hoffmann,et al.  Calpastatin Prevents NF-κB–Mediated Hyperactivation of Macrophages and Attenuates Colitis , 2013, The Journal of Immunology.

[5]  A. Tall,et al.  Deficiency of ATP-Binding Cassette Transporters A1 and G1 in Macrophages Increases Inflammation and Accelerates Atherosclerosis in Mice , 2013, Circulation research.

[6]  Se-hyung Park,et al.  Myeloid-Specific I&kgr;B Kinase &bgr; Deficiency Decreases Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[7]  Hao Wang,et al.  Deficiency of Capn4 Gene Inhibits Nuclear Factor-κB (NF-κB) Protein Signaling/Inflammation and Reduces Remodeling after Myocardial Infarction* , 2012, The Journal of Biological Chemistry.

[8]  P. Lagadec,et al.  Calpain 2‐dependent IκBα degradation mediates CPT‐11 secondary resistance in colorectal cancer xenografts , 2012, The Journal of pathology.

[9]  Alexia I. Bachir,et al.  Talin Contains A C-Terminal Calpain2 Cleavage Site Important In Focal Adhesion Dynamics , 2012, PloS one.

[10]  S. Yokoyama,et al.  Calpain-mediated ABCA1 degradation: post-translational regulation of ABCA1 for HDL biogenesis. , 2012, Biochimica et biophysica acta.

[11]  Deborah A. Howatt,et al.  Calpain Inhibition Attenuates Angiotensin II–induced Abdominal Aortic Aneurysms and Atherosclerosis in Low-density Lipoprotein Receptor–deficient Mice , 2012, Journal of cardiovascular pharmacology.

[12]  R. Norton,et al.  Selenoprotein K Is a Novel Target of m-Calpain, and Cleavage Is Regulated by Toll-like Receptor-induced Calpastatin in Macrophages* , 2011, The Journal of Biological Chemistry.

[13]  A. Chishti,et al.  Vital Role of the Calpain-Calpastatin System for Placental-Integrity-Dependent Embryonic Survival , 2011, Molecular and Cellular Biology.

[14]  D. Rader,et al.  Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/- mice during disease regression. , 2011, The Journal of clinical investigation.

[15]  Ashok Kumar,et al.  IL-6 Production Is Positively Regulated by Two Distinct Src Homology Domain 2-Containing Tyrosine Phosphatase-1 (SHP-1)–Dependent CCAAT/Enhancer-Binding Protein β and NF-κB Pathways and an SHP-1–Independent NF-κB Pathway in Lipopolysaccharide-Stimulated Bone Marrow-Derived Macrophages , 2011, The Journal of Immunology.

[16]  Ko Sato,et al.  Calpastatin, an endogenous calpain‐inhibitor protein, regulates the cleavage of the Cdk5 activator p35 to p25 , 2011, Journal of neurochemistry.

[17]  Brin Freund,et al.  A Novel Role for Calpain in the Endothelial Dysfunction Induced by Activation of Angiotensin II Type 1 Receptor Signaling , 2011, Circulation research.

[18]  Julia L. Gregory,et al.  Macrophage Migration Inhibitory Factor and CD74 Regulate Macrophage Chemotactic Responses via MAPK and Rho GTPase , 2011, The Journal of Immunology.

[19]  R. Charnigo,et al.  Endothelial Cell–Specific Deficiency of Ang II Type 1a Receptors Attenuates Ang II–Induced Ascending Aortic Aneurysms in LDL Receptor−/− Mice , 2011, Circulation research.

[20]  S. Eguchi,et al.  Protein Kinase C Upregulates Intercellular Adhesion Molecule-1 and Leukocyte-Endothelium Interactions in Hyperglycemia via Activation of Endothelial Expressed Calpain , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[21]  A. Daugherty,et al.  Angiotensin II infusion promotes ascending aortic aneurysms: attenuation by CCR2 deficiency in apoE−/− mice , 2010, Clinical science.

[22]  P. Trouvé,et al.  The Calpain, Caspase 12, Caspase 3 Cascade Leading to Apoptosis Is Altered in F508del-CFTR Expressing Cells , 2009, PloS one.

[23]  D. Milewicz,et al.  An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. , 2009, The Journal of clinical investigation.

[24]  A. Daugherty,et al.  Measuring Blood Pressure in Mice using Volume Pressure Recording, a Tail-cuff Method , 2009, Journal of visualized experiments : JoVE.

[25]  R. Charnigo,et al.  ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice. , 2009, American journal of physiology. Heart and circulatory physiology.

[26]  E. Letavernier,et al.  Targeting the Calpain/Calpastatin System as a New Strategy to Prevent Cardiovascular Remodeling in Angiotensin II–Induced Hypertension , 2008, Circulation research.

[27]  A. Tall,et al.  Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice. , 2007, The Journal of clinical investigation.

[28]  A. Daugherty,et al.  Bone Marrow Transplantation Reveals That Recipient AT1a Receptors Are Required to Initiate Angiotensin II–Induced Atherosclerosis and Aneurysms , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[29]  Alan Daugherty,et al.  Development of experimental designs for atherosclerosis studies in mice. , 2005, Methods.

[30]  A. Daugherty,et al.  Hypercholesterolemia Stimulates Angiotensin Peptide Synthesis and Contributes to Atherosclerosis Through the AT1A Receptor , 2004, Circulation.

[31]  D. E. Goll,et al.  Interaction of calpastatin with calpain: a review , 2004, Biological chemistry.

[32]  Georg Kraal,et al.  Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. , 2003, The Journal of clinical investigation.

[33]  A. Tall,et al.  Phosphorylation of a Pest Sequence in ABCA1 Promotes Calpain Degradation and Is Reversed by ApoA-I* , 2003, Journal of Biological Chemistry.

[34]  A. Daugherty,et al.  Aortic Dissection Precedes Formation of Aneurysms and Atherosclerosis in Angiotensin II-Infused, Apolipoprotein E-Deficient Mice , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[35]  D. E. Goll,et al.  The calpain system. , 2003, Physiological reviews.

[36]  P. Libby.  Inflammation in atherosclerosis , 2002, Nature.

[37]  O. Francone,et al.  Increased Atherosclerosis in Hyperlipidemic Mice With Inactivation of ABCA1 in Macrophages , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[38]  G. Remuzzi,et al.  Protein traffic activates NF-kB gene signaling and promotes MCP-1-dependent interstitial inflammation. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[39]  A Daugherty,et al.  Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. , 2000, The Journal of clinical investigation.

[40]  S. Shumway,et al.  The PEST Domain of IκBα Is Necessary and Sufficient forin Vitro Degradation by μ-Calpain* , 1999, The Journal of Biological Chemistry.

[41]  P. Libby,et al.  Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. , 1998, Molecular cell.

[42]  A. Daugherty,et al.  Absence of T lymphocyte-derived cytokines fails to diminish macrophage 12/15-lipoxygenase expression in vivo. , 1998, Journal of immunology.

[43]  T. Lorca,et al.  Differential sensitivity of FOS and JUN family members to calpains. , 1994, Oncogene.

[44]  H. Kawasaki,et al.  Degradation of transcription factors, c‐Jun and c‐Fos, by calpain , 1991, FEBS letters.

[45]  N. Perkins,et al.  Integrating cell-signalling pathways with NF-kappaB and IKK function. , 2007, Nature reviews. Molecular cell biology.

[46]  P. Linsel-Nitschke,et al.  A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I. , 2003, The Journal of clinical investigation.

[47]  F. Chen,et al.  Impairment of NF-kappaB activation and modulation of gene expression by calpastatin. , 2000, American Journal of Physiology - Cell Physiology.

[48]  D. Green,et al.  Calpain functions in a caspase-independent manner to promote apoptosis-like events during platelet activation. , 1999, Blood.